Research study Program year 2020 Source: CMS Open Payments

Rota-096

Research payments

$747,534

190 payments

Through program year 2020, $747,534 in research payments was reported against Rota-096, across 190 payments, paid by GlaxoSmithKline, LLC..

Paid by: GlaxoSmithKline, LLC.
ClinicalTrials.gov: No trial number was reported for this study

By program year

2 rows

Year	Kind	Amount	Payments
2020	Research	$604,792	172
2019	Research	$142,742	18

Breakdown

Who paid Research payments · program years 2019–2020

GlaxoSmithKline, LLC. $747,534 190 payments

Who received the money Research payments · program years 2019–2020

Midwest Children's Health Research Insitute Organisation paid for research $160,094 48 payments
Pharmaceutical Research Organization Organisation paid for research $155,234 33 payments
University Of Maryland Baltimore Foundation Inc Organisation paid for research $96,296 21 payments
Jbr Clinical Research Organisation paid for research $77,771 15 payments
Davita Clinical Research Organisation paid for research $40,054 9 payments
The Corvallis Clinic Organisation paid for research $38,036 6 payments
The Research Foundation For The State University Of New York Organisation paid for research $38,008 6 payments
Alabama Clinical Therapeutics Organisation paid for research $17,906 6 payments
Medical Center Pediatrics Pllc Organisation paid for research $17,823 7 payments
J Lewis Research INC Organisation paid for research $16,715 6 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.